The New Psoriasis Paradigm: Striving for Complete Clearance

Area of Science:

• Dermatology
• Pharmacology

Background:

• Biologic therapies have advanced psoriasis treatment, offering unprecedented clearance rates.
• Achieving high levels of skin clearance, such as PASI 90 and PASI 100, is now attainable for many patients.
• Improved quality of life is linked to higher clearance levels, but data on comorbidities is limited.

Purpose of the Study:

• To evaluate the clinical benefits of achieving higher clearance levels with newer biologics.
• To explore the relationship between total skin clearance and improvements in patient comorbidities.
• To discuss whether dermatologists should aim for total clearance in psoriasis management.

Main Methods:

• Review of existing clinical data on newer biologic therapies for psoriasis.
• Analysis of the association between varying levels of skin clearance (PASI 90, PASI 100, total clearance) and quality of life metrics.
• Examination of available evidence regarding the impact of high clearance on comorbidities.

Main Results:

• Newer biologics facilitate higher and more complete skin clearance rates than previously possible.
• Total skin clearance is associated with significant improvements in quality of life.
• Limited data currently exists on the clinical benefits of higher clearance levels concerning comorbidities.

Conclusions:

• Higher clearance rates, including total clearance, are achievable with modern biologics and enhance patient quality of life.
• Further investigation is warranted to understand the full clinical benefits of high clearance, especially regarding comorbidities.
• Dermatologists should consider striving for total skin clearance as a realistic treatment goal for patients with psoriasis.